Table 1.
Subject demographic, clinical and data for healthy controls, PD patients on MAO-I and levodopa, and PD patients on monotherapy (levodopa or dopamine agonists only).
| PD Patients on MAO-I and Ldopa | PD Patients on Ldopa or DA agonists only | Healthy Controls | P-value | |
|---|---|---|---|---|
| N | 37 | 39 | 43 | |
| Age | 65.2 (4.6) | 67.3 (4.3) | 66.9 (5.2) | 0.304 |
| Sex (M/F) | 26/11 | 27/12 | 29/14 | 0.48 |
| PD (akinetic-rigid/Tremor) | 21/16 | 22/17 | – | 0.734 |
| Education (years) | 13.1 (2.3) | 12.9 (2.2) | 13.2 (3.1) | 0.21 |
| NART-predicted IQ | 109.5 (12.7) | 114.5 (13.1) | 116.5 (9.7) | 0.53 |
| MMSE | 27.4 (1.1) | 27.7 (1.4) | 28.2 (1.9) | 0.420 |
| NAART | 34.2 (11.8) | 34.8 (11.4) | 36.9 (7.3) | 0.312 |
| H and Y | 2.61 (0.4) | 2.53 (0.5) | – | 0.601 |
| UPDRS | 18.9 (5.9) | 23.8 (5.2) | – | 0.094 |
| FOGQ | 2.6 (0.6) | 3.1 (0.7) | – | 0.09 |
| Disease duration | 8.61 (4.1) | 8.46 (3.8) | – | 0.732 |
Values here represent Mean (S.D). Abbreviations: H and Y, Hoehn and Yahr staging of PD; NAART, North American Adult Reading Test; MMSE, Mini-Mental State Examination; FOGQ, Freezing of Gait Questionnaire; UPDRS, Unified Parkinson’s Disease Rating Scale.